Imperial College London, London, United Kingdom
Jesus Rodriguez-Manzano received a BSc in Biological Sciences, an MSc in Advanced Microbiology, and a PhD in Biotechnology and Environmental Microbiology from the University of Barcelona. After post-doctoral positions in the Division of Chemistry and Chemical Engineering at the California Institute of Technology (Caltech) and in the Department of Electrical and Electronic Engineering at Imperial College London, he moved to the Department of Infectious Disease as a non-clinical Lecturer in Antimicrobial Resistance and Infectious Diseases in the Faculty of Medicine. He is a Co-Founder and CSO of ProtonDx Ltd, an Imperial spinout company developing diagnostic solutions to guide treatment decisions, optimise antimicrobial use and support infection control interventions; and the Deputy Director of the Centre for Antimicrobial Optimisation (CAMO) at Imperial College. Dr. Rodriguez-Manzano has a strong interdisciplinary background in microbiology, molecular biology, and bioengineering, and his research interest includes single-molecule technologies, machine learning applied to healthcare, and clinical diagnostics, with a particular interest in low- and middle-income countries. He is the author of over 80 scientific publications and 14 international patent applications.